Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC
Where
Jinan
Age
18 years and over
People
560
Run by
Akeso
See details and how to joinNCT06617416
Phase 2Taking people
Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung Cancer
Where
Guangzhou
Age
18 years and over
People
52
Run by
Sun Yat-sen University
See details and how to joinNCT06730295
No phaseTaking people
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
Where
Beijing
Age
18 years to 75 years
People
65
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT06869239
Phase 2Taking people
Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC
Where
Hangzhou
Age
18 years and over
People
78
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06863506
Phase 2Taking people
The Efficacy and Safety of the Bispecific Anti-PD-1/PD-L1 Antibody IBI318 Combined with Lenvatinib in NSCLC.
Where
Changsha
Age
18 years to 75 years
People
120
Run by
Hunan Province Tumor Hospital
See details and how to joinNCT04777084
No phaseTaking people
Second-line Immunotherapy for ES-SCLC
Where
Tianjin
Age
18 years and over
People
30
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06853678
Phase 1Taking people
Personalized DC Vaccine for Postoperative Cancer
Where
Chengdu
Age
18 years to 100 years
People
80
Run by
Sichuan University
See details and how to joinNCT04147078
Phase 2Not yet taking people in China
Tislelizumab in Combination with Chemotherapy ± Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer.
Where
Shijiazhuang
Age
18 years and over
People
64
Run by
Hebei Medical University Fourth Hospital
See details and how to joinNCT06851819
No phaseTaking people
The Regression Pattern of Primary Lesions in Lung Cancer After Definitive Radiotherapy
Where
Beijing, Wuhan
Age
18 years and over
People
500
Run by
China-Japan Friendship Hospital
See details and how to joinNCT06692972
No phaseNot yet taking people in China
Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial
Where
Nanchang
Age
18 years to 75 years
People
100
Run by
Jiangxi Provincial People's Hopital
See details and how to joinNCT06848426
Phase 2Taking people
Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC
Where
Beijing
Age
18 years to 70 years
People
63
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT06849167
No phaseTaking people
DREAM Study: DNA/RNA-NGS Co-Testing in Driver-Negative, Treatment-Resistant NSCLC
Where
Shanghai
People
508
Run by
Baohui Han
See details and how to joinNCT06846762
No phaseTaking people
The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)
Where
Changsha
Age
18 years and over
People
750
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT05477979
No phaseTaking people
Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.
Where
Guangzhou
Age
18 years to 75 years
People
2,500
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06843707
Phase 1Taking people
TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies
Where
Hangzhou
Age
18 years and over
People
90
Run by
Shenzhen TargetRx Co., Ltd.
See details and how to joinNCT06484816
No phaseTaking people
Association Between RVT and Prognosis After Neoadjuvant Targeted Therapy in EGFR NSCLC
Where
Guangzhou
Age
18 years to 80 years
People
120
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT06771960
Phase 2Not yet taking people in China
Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC
Where
Shanghai
Age
18 years and over
People
160
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06837948
Phase 3Not yet taking people in China
Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer
Where
Changsha
Age
18 years and over
People
94
Run by
Hunan Province Tumor Hospital
See details and how to joinNCT06828757
No phaseTaking people
Research on Building and Application of Internet-based Home Pre-rehabilitation Model for Lung Surgery Patients.
Where
Yiwu
Age
60 years to 99 years
People
100
Run by
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
See details and how to joinNCT06458894
No phaseTaking people
Survival Outcomes of Lung Cancer
Where
Changsha
Age
18 years and over
People
20,000
Run by
Hunan Province Tumor Hospital
See details and how to joinNCT03647098
Phase 2Taking people
First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC
Where
Wuhan
Age
18 years and over
People
45
Run by
Xiaorong Dong
See details and how to joinNCT05745350
Phase 1Taking people
Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer
Where
Changsha, Fuzhou, Hangzhou, Hefei, Jinan, Nanchang, Zhengzhou
Age
18 years to 75 years
People
190 worldwide
Run by
Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT06613009 · EU 2025-523972-21-00
Phase 2Not yet taking people in China
Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study
Where
Dalian, Shenyang
Age
18 years to 75 years
People
40
Run by
The Second Affiliated Hospital of Dalian Medical University
See details and how to joinNCT06820762
Phase 1/2Taking people
Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients
Where
Hangzhou
Age
10 years to 80 years
People
150
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06023212
Phase 2Taking people
Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC
Where
Hefei
Age
18 years and over
People
86
Run by
Anhui Provincial Cancer Hospital
See details and how to joinNCT06714708